Improving your skills in the diagnosis and treatment of this type of cancer will save the lives of your patients. Study at TECH and get a quality qualification"

For adults, a cancer is considered rare when its annual incidence is less than 6 cases per 100,000 people. It is estimated that they represent up to 24% of the cancers diagnosed in the European Union and around 20% of the cancers diagnosed in the United States. Specifically, this program prepares students to recognize the different entities that make up this group of pathologies: uncommon, rare and ultra-rare cancers; orphan tumors; agnostic tumors; and cancers of Unkown Primary. 

The student will be able to place these entities in an epidemiological context, specialize in their incidence and prevalence, as well as the trend of the rates at European and national level. In addition, the student will learn in depth the survival data at European and national level, and the causes of the differences in survival between rare tumors and reference tumor pathology. Furthermore, this program allows the student an approach to precision medicine in the context of rare tumors, agnostic treatments and cancer of Unkown Primary. Through problem-solving through different clinical experiences with precision medicine in uncommon tumors, you will be able to apply genomics in the diagnosis and treatment of infrequent tumors. 

In this program, the experts, all of them referents in each field of knowledge, will develop aspects related to the context of this spectrum of pathologies, will present the clinical and molecular vision, will show their diagnostic and therapeutic approaches and will explain complementary aspects such as their research and institutional environment or the global reality of the patients who suffer from them. 

In addition, students will be able to complete the program at their own pace, without being subject to fixed schedules or the travel involved in classroom teaching, so they can combine it with the rest of their daily obligations. 

Learn about the latest developments in this type of pathology, you will contribute to science with your future diagnoses and advance in your daily work"

This postgraduate certificate in Reality of Orphan, Agnostic Tumors and Tumors of Unknown Primary contains the most complete and up-to-date scientific program on the market. Its most notable features are:

• Case studies presented by experts in oncology 
• The graphic, schematic, and practical contents with which they are created, provide scientific and practical information on the disciplines that are essential for professional development
• Developments on Reality of Orphan, Agnostic Tumors and Tumors of Unknown Primary 
• Practical exercises where the self-assessment process can be carried out to improve learning 
• Its special emphasis on innovative methodologies in the diagnosis and treatment of Reality of Orphan, Agnostic Tumors and Tumors of Unknown Primary
• Theoretical lessons, questions to the expert, debate forums on controversial topics, and individual reflection work
• Content that is accessible from any fixed or portable device with an Internet connection 

This postgraduate certificate is the best investment you can make in the selection of a refresher program for two reasons: in addition to updating your knowledge in Reality of Orphan, Agnostic Tumors and Tumors of Unknown Primary , you will obtain a qualification endorsed by the leading online university in Spanish: TECH”

The teaching staff includes professionals from the Oncology sector, who bring their experience to this educational program, as well as renowned specialists from leading societies and prestigious universities. 

The multimedia content, developed with the latest educational technology, will provide the professional with situated and contextual learning, i.e., a simulated environment that will provide immersive knowledge programmed to learn in real situations. 

This program is designed around Problem-Based Learning, whereby the specialist must try to solve the different professional practice situations that arise throughout the program. For this purpose, the professional will be assisted by an innovative interactive video system created by renowned and experienced experts.   

With this program you will delve into the causes of survival differences between rare tumors and reference tumor pathology"

Approach precision medicine in the context of rare tumors, agnostic treatments and cancer of Unkown Primary and boost your academic career"

The design of this postgraduate certificate in Reality of Orphan, Agnostic Tumors and Tumors of Unknown Primary will allow the student to delve into a field of medicine that is in constant research. This way, you will update your professional profile and boost your career in a field of study in which there is a lack of specialists. The program has been designed by a team of experts with contents that will enable the future graduate to reach the proposed objectives. However, you will be fully empowered to deal with the latest advances and the newest treatments currently being applied. For this reason, TECH has established a series of general and specific objectives for the satisfaction of future graduates, asfollows:  

TECH has only one goal: to increase your chances of professional success"

General objectives

• Acquire concepts and knowledge regarding the epidemiology, clinical, diagnosis and treatment of infrequent tumors, agnostic diagnoses and cancers of Unkown Primary
• Know how to apply the diagnostic algorithms and evaluate the prognosis of this pathology
• Be able to integrate knowledge and face the complexity of formulating clinical and diagnostic judgments based on the available clinical information
• Know how to apply acquired knowledge and problem-solving skills in new or unfamiliar environments within broader (or multidisciplinary) contexts related to the area of study
• Know how to establish complex therapeutic plans in the context of the pathology in question Have a deeper knowledge of specific treatment networks, reference centers, clinical trials
• Incorporate new technologies into daily practice, knowing their advances, limitations and future potential
• Acquire knowledge about molecular biology tools for the study of these tumors
• Have thorough knowledge and use Tumor Registries
• Know and use the face-to-face or virtual Molecular Committees
• Understand fundamental aspects of biobank operation
• Specialize in interprofessional relationship tools for the treatment of orphan, agnostic and cancer of Unkown Primary and to access expert networks in the different pathology groups
• Know how to apply knowledge to solve clinical and research problems in the area of rare pathology
• Know how to communicate conclusions, knowledge, and supporting arguments to specialized and non-specialized audiences in a clear and unambiguous way
• Acquire the learning skills to enable further studying in a largely self-directed or autonomous manner
• Possess and understand knowledge that provides a basis or opportunity to be original when developing and/or applying ideas, often in a research context
• Understand the social responsibility due to rare diseases 

Specific objectives

• Be able to place the entities under study in an epidemiological context, to know their incidence and prevalence, as well as the trend of the rates at European level
• Delve into the survival data at European level and the causes of the survival of the differences in survival between rare tumors and reference tumor pathology
• Gain an in-depth understanding of aspects related to precision medicine in the context of rare tumors, agnostic treatments and cancer of Unkown Primary
• Handle the different models of care for rare tumors, as well as concepts in their field such as tumor registries, expert networks, reference units and tumor board review
• Acquire training on biobanks and their role in clinical research
• Become familiar with the methodological aspects of low incidence tumor research
• Specialize in the European framework of legislation in relation to low incidence tumors, the role of regulatory agencies and the particularities of access to drugs to drugs
• Be aware of the implications of all this in the patient's experience, as well as the repercussions of the disease at the psychological and social level

Take the opportunity and take the step to get up to date on the latest developments in Reality of Orphan, Agnostic Tumors and Tumors of Unknown Primary "